研究人员通过识别脊髓液中的Tau蛋白,开发新的测试,以早期检测阿尔茨海默氏症。 Researchers develop a new test to detect Alzheimer's earlier by identifying tau protein in spinal fluid.

匹兹堡大学的研究人员开发了一个新的生物标志测试,通过在脑脊椎液中鉴定陶伊蛋白,可以更早地检测阿尔茨海默氏病。 Researchers at the University of Pittsburgh have developed a new biomarker test that can detect Alzheimer's disease earlier by identifying tau protein in cerebrospinal fluid. 测试与认知下降相关,可以在脑损伤严重之前诊断该疾病,从而有可能改善治疗结果。 The test correlates with cognitive decline and can diagnose the disease before significant brain damage occurs, potentially improving treatment outcomes. 这一进步可能导致早期干预和更有效地治疗阿尔茨海默氏病。 This advancement could lead to earlier intervention and more effective treatments for Alzheimer's.